» Articles » PMID: 35519543

Using Molecular Dynamics Simulations to Evaluate Active Designs of Cephradine Hydrolase by Molecular Mechanics/Poisson-Boltzmann Surface Area and Molecular Mechanics/generalized Born Surface Area Methods

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 6
PMID 35519543
Authors
Affiliations
Soon will be listed here.
Abstract

The poor predictive accuracy of current computational enzyme design methods has led to low success rates of producing highly active variants that target non-natural substrates. In this report, a quantitative assessment approach based on molecular dynamics (MD) simulations was developed to eliminate false-positive enzyme designs at the computational stage. Taking cephradine hydrolase as an example, the apparent Michaelis binding constant ( ) and catalytic efficiency ( / ) of designed variants were correlated with binding free energies and activation energy barriers, respectively, as calculated by molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) and molecular mechanics/generalized Born surface area (MM/GBSA) methods with explicit water considered based on general MD simulation protocols. The correlation results showed that both the MM/GBSA and MM/PBSA methods with a protein dielectric constant ( = 4) could rank the variants well based on the predicted binding free energies between enzyme and the substrate. Furthermore, the activation energy barriers calculated by the MM/PBSA method with an = 24 correlated well with / . Thus, false-positive variants obtained by the enzyme design program PRODA were eliminated prior to experimentation. Therefore, MD simulation-based quantitative assessment of designed variants greatly enhanced the predictive accuracy of computational enzyme design tools and should facilitate the construction of artificial enzymes with high catalytic activities toward non-natural substrates.

Citing Articles

3D-QSAR, design, molecular docking and dynamics simulation studies of novel 6-hydroxybenzothiazole-2-carboxamides as potentially potent and selective monoamine oxidase B inhibitors.

Xie D, Tian Y, Cao L, Guo P, Cai Z, Zhou J Front Pharmacol. 2025; 16:1545791.

PMID: 39981188 PMC: 11841475. DOI: 10.3389/fphar.2025.1545791.


Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction.

Maani Z, Farajnia S, Rahbarnia L, Zadeh Hosseingholi E, Khajehnasiri N, Mansouri P J Mol Struct. 2022; 1272:134160.

PMID: 36128074 PMC: 9479519. DOI: 10.1016/j.molstruc.2022.134160.


Recent Developments in Free Energy Calculations for Drug Discovery.

King E, Aitchison E, Li H, Luo R Front Mol Biosci. 2021; 8:712085.

PMID: 34458321 PMC: 8387144. DOI: 10.3389/fmolb.2021.712085.


Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.

Huang X, Pearce R, Omenn G, Zhang Y Int J Mol Sci. 2021; 22(13).

PMID: 34209110 PMC: 8269196. DOI: 10.3390/ijms22137060.


Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering.

Ong E, Huang X, Pearce R, Zhang Y, He Y Comput Struct Biotechnol J. 2021; 19:518-529.

PMID: 33398234 PMC: 7773544. DOI: 10.1016/j.csbj.2020.12.039.

References
1.
Frushicheva M, Cao J, Chu Z, Warshel A . Exploring challenges in rational enzyme design by simulating the catalysis in artificial kemp eliminase. Proc Natl Acad Sci U S A. 2010; 107(39):16869-74. PMC: 2947920. DOI: 10.1073/pnas.1010381107. View

2.
Xiang Z, Honig B . Extending the accuracy limits of prediction for side-chain conformations. J Mol Biol. 2001; 311(2):421-30. DOI: 10.1006/jmbi.2001.4865. View

3.
Li R, Wijma H, Song L, Cui Y, Otzen M, Tian Y . Computational redesign of enzymes for regio- and enantioselective hydroamination. Nat Chem Biol. 2018; 14(7):664-670. DOI: 10.1038/s41589-018-0053-0. View

4.
Price D, Jorgensen W . Improved convergence of binding affinities with free energy perturbation: application to nonpeptide ligands with pp60src SH2 domain. J Comput Aided Mol Des. 2001; 15(8):681-95. DOI: 10.1023/a:1012266200343. View

5.
Gordon S, Stanley E, Wolf S, Toland A, Wu S, Hadidi D . Computational design of an α-gliadin peptidase. J Am Chem Soc. 2012; 134(50):20513-20. PMC: 3526107. DOI: 10.1021/ja3094795. View